(AMCR) Amcor - Overview
Exchange: NYSE •
Country: Switzerland •
Currency: USD •
Type: Common Stock •
ISIN: JE00BJ1F3079
Stock:
Total Rating 28
Risk 54
Buy Signal -0.21
| Risk 5d forecast | |
|---|---|
| Volatility | 24.8% |
| Relative Tail Risk | -6.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -9.57 |
| Character TTM | |
|---|---|
| Beta | 0.359 |
| Beta Downside | 0.490 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.38% |
| CAGR/Max DD | 0.02 |
EPS (Earnings per Share)
Revenue
Description: AMCR Amcor
Amcor plc, together with its subsidiaries, engages in the production and sale of packaging products in Europe, North America, Latin America, and the Asia Pacific. The company operates in two segments, Global Flexible Packaging Solutions and Global Rigid Packaging Solutions. The Global Flexible Packaging Solutions segment develops and supplies flexible packaging products, including polymer resin, aluminum, and fiber based flexible packaging products to the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries. The Global Rigid Packaging Solutions segment manufactures rigid packaging containers, closures, dispensing and pharma devices, and related products for the food and beverage applications. The company sells its products through its direct sales force. The company was incorporated in 1926 and is headquartered in Zurich, Switzerland.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: 596.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.36 > 1.0 |
| NWC/Revenue: 10.10% < 20% (prev 7.44%; Δ 2.65% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.60b > Net Income 596.0m |
| Net Debt (15.84b) to EBITDA (2.57b): 6.17 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (463.8m) vs 12m ago 60.48% < -2% |
| Gross Margin: 18.20% > 18% (prev 0.20%; Δ 1799 % > 0.5%) |
| Asset Turnover: 73.70% > 50% (prev 83.76%; Δ -10.06% > 0%) |
| Interest Coverage Ratio: 2.21 > 6 (EBITDA TTM 2.57b / Interest Expense TTM 559.0m) |
Altman Z'' 0.67
| A: 0.05 (Total Current Assets 8.56b - Total Current Liabilities 6.58b) / Total Assets 37.05b |
| B: 0.01 (Retained Earnings 393.0m / Total Assets 37.05b) |
| C: 0.05 (EBIT TTM 1.24b / Avg Total Assets 26.61b) |
| D: -0.02 (Book Value of Equity -579.0m / Total Liabilities 25.40b) |
| Altman-Z'' Score: 0.67 = B |
Beneish M -2.32
| DSRI: 1.23 (Receivables 3.16b/1.77b, Revenue 19.61b/13.54b) |
| GMI: 1.11 (GM 18.20% / 20.17%) |
| AQI: 1.21 (AQ_t 0.53 / AQ_t-1 0.44) |
| SGI: 1.45 (Revenue 19.61b / 13.54b) |
| TATA: -0.03 (NI 596.0m - CFO 1.60b) / TA 37.05b) |
| Beneish M-Score: -2.32 (Cap -4..+1) = BBB |
What is the price of AMCR shares?
As of March 04, 2026, the stock is trading at USD 47.17 with a total of 4,581,475 shares traded.
Over the past week, the price has changed by -4.76%, over one month by +6.39%, over three months by +12.98% and over the past year by -1.34%.
Over the past week, the price has changed by -4.76%, over one month by +6.39%, over three months by +12.98% and over the past year by -1.34%.
Is AMCR a buy, sell or hold?
Amcor has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy AMCR.
- StrongBuy: 3
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AMCR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.5 | 13.4% |
| Analysts Target Price | 53.5 | 13.4% |
AMCR Fundamental Data Overview March 02, 2026
P/E Trailing = 36.4135
P/E Forward = 11.976
P/S = 1.1412
P/B = 1.9231
P/EG = 0.5985
Revenue TTM = 19.61b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 2.57b USD
Long Term Debt = 14.62b USD (from longTermDebt, last quarter)
Short Term Debt = 519.0m USD (from shortTermDebt, last quarter)
Debt = 16.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.84b USD (from netDebt column, last quarter)
Enterprise Value = 38.22b USD (22.38b + Debt 16.90b - CCE 1.06b)
Interest Coverage Ratio = 2.21 (Ebit TTM 1.24b / Interest Expense TTM 559.0m)
EV/FCF = 23.53x (Enterprise Value 38.22b / FCF TTM 1.62b)
FCF Yield = 4.25% (FCF TTM 1.62b / Enterprise Value 38.22b)
FCF Margin = 8.28% (FCF TTM 1.62b / Revenue TTM 19.61b)
Net Margin = 3.04% (Net Income TTM 596.0m / Revenue TTM 19.61b)
Gross Margin = 18.20% ((Revenue TTM 19.61b - Cost of Revenue TTM 16.04b) / Revenue TTM)
Gross Margin QoQ = 16.43% (prev 19.56%)
Tobins Q-Ratio = 1.03 (Enterprise Value 38.22b / Total Assets 37.05b)
Interest Expense / Debt = 0.91% (Interest Expense 154.0m / Debt 16.90b)
Taxrate = 1.67% (3.00m / 180.0m)
NOPAT = 1.22b (EBIT 1.24b * (1 - 1.67%))
Current Ratio = 1.30 (Total Current Assets 8.56b / Total Current Liabilities 6.58b)
Debt / Equity = 1.45 (Debt 16.90b / totalStockholderEquity, last quarter 11.64b)
Debt / EBITDA = 6.17 (Net Debt 15.84b / EBITDA 2.57b)
Debt / FCF = 9.76 (Net Debt 15.84b / FCF TTM 1.62b)
Total Stockholder Equity = 9.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.24% (Net Income 596.0m / Total Assets 37.05b)
RoE = 6.12% (Net Income TTM 596.0m / Total Stockholder Equity 9.73b)
RoCE = 5.08% (EBIT 1.24b / Capital Employed (Equity 9.73b + L.T.Debt 14.62b))
RoIC = 5.31% (NOPAT 1.22b / Invested Capital 22.95b)
WACC = 4.51% (E(22.38b)/V(39.28b) * Re(7.24%) + D(16.90b)/V(39.28b) * Rd(0.91%) * (1-Tc(0.02)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 26.90%
[DCF] Terminal Value 87.13% ; FCFF base≈1.28b ; Y1≈1.39b ; Y5≈1.74b
[DCF] Fair Price = 77.21 (EV 51.52b - Net Debt 15.84b = Equity 35.68b / Shares 462.0m; r=5.90% [WACC]; 5y FCF grow 9.92% → 2.90% )
EPS Correlation: -32.11 | EPS CAGR: -3.94% | SUE: 0.34 | # QB: 0
Revenue Correlation: 46.39 | Revenue CAGR: 10.81% | SUE: -1.42 | # QB: 0
EPS current Year (2026-06-30): EPS=3.98 | Chg7d=-0.015 | Chg30d=-0.048 | Revisions Net=-4 | Growth EPS=+11.9% | Growth Revenue=+52.9%
EPS next Year (2027-06-30): EPS=4.42 | Chg7d=-0.008 | Chg30d=-0.035 | Revisions Net=-2 | Growth EPS=+11.0% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: -0.50 (2 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 5.2% (Discount Rate 7.9% - Earnings Yield 2.7%)
[Growth] Growth Spread = -3.5% (Analyst 1.7% - Implied 5.2%)
P/E Forward = 11.976
P/S = 1.1412
P/B = 1.9231
P/EG = 0.5985
Revenue TTM = 19.61b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 2.57b USD
Long Term Debt = 14.62b USD (from longTermDebt, last quarter)
Short Term Debt = 519.0m USD (from shortTermDebt, last quarter)
Debt = 16.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.84b USD (from netDebt column, last quarter)
Enterprise Value = 38.22b USD (22.38b + Debt 16.90b - CCE 1.06b)
Interest Coverage Ratio = 2.21 (Ebit TTM 1.24b / Interest Expense TTM 559.0m)
EV/FCF = 23.53x (Enterprise Value 38.22b / FCF TTM 1.62b)
FCF Yield = 4.25% (FCF TTM 1.62b / Enterprise Value 38.22b)
FCF Margin = 8.28% (FCF TTM 1.62b / Revenue TTM 19.61b)
Net Margin = 3.04% (Net Income TTM 596.0m / Revenue TTM 19.61b)
Gross Margin = 18.20% ((Revenue TTM 19.61b - Cost of Revenue TTM 16.04b) / Revenue TTM)
Gross Margin QoQ = 16.43% (prev 19.56%)
Tobins Q-Ratio = 1.03 (Enterprise Value 38.22b / Total Assets 37.05b)
Interest Expense / Debt = 0.91% (Interest Expense 154.0m / Debt 16.90b)
Taxrate = 1.67% (3.00m / 180.0m)
NOPAT = 1.22b (EBIT 1.24b * (1 - 1.67%))
Current Ratio = 1.30 (Total Current Assets 8.56b / Total Current Liabilities 6.58b)
Debt / Equity = 1.45 (Debt 16.90b / totalStockholderEquity, last quarter 11.64b)
Debt / EBITDA = 6.17 (Net Debt 15.84b / EBITDA 2.57b)
Debt / FCF = 9.76 (Net Debt 15.84b / FCF TTM 1.62b)
Total Stockholder Equity = 9.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.24% (Net Income 596.0m / Total Assets 37.05b)
RoE = 6.12% (Net Income TTM 596.0m / Total Stockholder Equity 9.73b)
RoCE = 5.08% (EBIT 1.24b / Capital Employed (Equity 9.73b + L.T.Debt 14.62b))
RoIC = 5.31% (NOPAT 1.22b / Invested Capital 22.95b)
WACC = 4.51% (E(22.38b)/V(39.28b) * Re(7.24%) + D(16.90b)/V(39.28b) * Rd(0.91%) * (1-Tc(0.02)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 26.90%
[DCF] Terminal Value 87.13% ; FCFF base≈1.28b ; Y1≈1.39b ; Y5≈1.74b
[DCF] Fair Price = 77.21 (EV 51.52b - Net Debt 15.84b = Equity 35.68b / Shares 462.0m; r=5.90% [WACC]; 5y FCF grow 9.92% → 2.90% )
EPS Correlation: -32.11 | EPS CAGR: -3.94% | SUE: 0.34 | # QB: 0
Revenue Correlation: 46.39 | Revenue CAGR: 10.81% | SUE: -1.42 | # QB: 0
EPS current Year (2026-06-30): EPS=3.98 | Chg7d=-0.015 | Chg30d=-0.048 | Revisions Net=-4 | Growth EPS=+11.9% | Growth Revenue=+52.9%
EPS next Year (2027-06-30): EPS=4.42 | Chg7d=-0.008 | Chg30d=-0.035 | Revisions Net=-2 | Growth EPS=+11.0% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: -0.50 (2 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 5.2% (Discount Rate 7.9% - Earnings Yield 2.7%)
[Growth] Growth Spread = -3.5% (Analyst 1.7% - Implied 5.2%)